Johnson & Johnson

Johnson & Johnson
Company typePublic
Traded as
  • NYSE: JNJ
  • DJIA component
  • S&P 100 component
  • S&P 500 component
ISINUS4781601046
Industry
FoundedJanuary 1886 (1886-01) in New Brunswick, New Jersey, U.S.
Founders
  • Robert Wood Johnson I
  • James Wood Johnson
  • Edward Mead Johnson
HeadquartersJohnson and Johnson Plaza,
New Brunswick, New Jersey
,
U.S.
40°29′55″N 74°26′37″W / 40.49861°N 74.44361°W / 40.49861; -74.44361
Area served
Worldwide
Key people
  • Joaquin Duato (chairman & CEO)
ProductsList of Johnson & Johnson products and services
Revenue US$88.82 billion (2024)
Operating income
US$20.80 billion (2024)
Net income
US$14.07 billion (2024)
Total assets US$180.1 billion (2024)
Total equity US$71.49 billion (2024)
Number of employees
138,100 (2024)
Subsidiaries
  • Johnson & Johnson Pharmaceutical Research and Development
    • Actelion Pharmaceuticals
    • Cilag
    • Janssen Biologics
    • Janssen Global Services
    • Janssen Therapeutics
    • Janssen Vaccines & Prevention
    • Momenta Pharmaceuticals
  • Johnson & Johnson MedTech
    • Abiomed
    • Acclarent
    • Biosense Webster
    • Cerenovus
    • DePuy Synthes
    • Ethicon
    • Johnson & Johnson Vision
    • Mentor
    • Synthes
    • V-Wave
    • Shockwave Medical
  • Johnson & Johnson Services
Websitejnj.com
Footnotes / references

Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 42 on the 2024 Fortune 500 list of the largest United States corporations. In 2024, the company was ranked 45th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.

Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business segment into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharmaceutical prescription drugs and medical device technologies.

Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.